InvestorsObserver
×
News Home

Where Does Pfizer Inc (PFE) Stock Fall in the Drug Manufacturers - General Field After It Is Higher By 0.80% This Week?

Thursday, March 28, 2024 11:01 AM | InvestorsObserver Analysts

Mentioned in this article

Where Does Pfizer Inc (PFE) Stock Fall in the Drug Manufacturers - General Field After It Is Higher By 0.80% This Week?

The 31 rating InvestorsObserver gives to Pfizer Inc (PFE) stock puts it near the middle of the Drug Manufacturers - General industry. In addition to scoring higher than 35 percent of stocks in the Drug Manufacturers - General industry, PFE’s 31 overall rating means the stock scores better than 31 percent of all stocks.

Overall Score - 31
PFE has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on PFE!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Pfizer Inc Stock Today?

Pfizer Inc (PFE) stock is trading at $27.88 as of 10:54 AM on Thursday, Mar 28, a rise of $0.10, or 0.36% from the previous closing price of $27.78. The stock has traded between $27.72 and $27.93 so far today. Volume today is low. So far 6,298,759 shares have traded compared to average volume of 41,945,527 shares. Click Here to get the full Stock Report for Pfizer Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App